Kwon kyung yup biography of abraham
•
Cited by CrossRef (84)
- Chi Lan Tran, Minji Han, Byungmi Kim, Eun Young Park, Young Il Kim, Jin‐Kyoung Oh. Gastroesophageal reflux disease and risk of cancer: Findings from the Korean National Health Screening Cohort. Cancer Medicine 2023;12:19163
- Mun Young Cho, Yu Kyung Cho. Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders. Korean J Helicobacter Up Gastrointest Res 2023;23:167
- 振慧 段. The Clinical Characteristics of Patients with Esophageal Hiatal Hernia Combined with Reflux Esophagitis. ACM 2024;14:4638
- Liu Fangxu, Li Wenbin, Zhang Pan, Chen Dan, Wu Xi, Xu Xue, Shi Jihua, Luo Qingfeng, Xu Le, Zheng Songbai. Chinese expert consensus on diagnosis and management of gastroesophageal reflux disease in the elderly (2023). Aging Medicine 2024;7:143
- Ho-Sook Kim, Young-Kyung Choi, Minkyung Oh, Yong-Soon Cho, Jong-Lyul Ghim. Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegopraz
•
Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients
INTRODUCTION
Breast cancer fryst vatten one of the most prevalent cancers worldwide, with over 1,300,000 newly diagnosed patients and 450,000 deaths each year [1]. Breast cancer is a highly heterogeneous disease with diverse pathophysiological and clinical features that can be caused by distinct genetic, epigenetic, and transcriptomic changes. Based on expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), breast cancer can be categorized into three subtypes: hormone receptor-positive (ER+ or PR+), HER2-positive (ER-, PR-, and HER2+), and triple-negative breast cancer (TNBC) (ER-, PR-, and HER-) types [2, 3]. TNBC accounts for approximately 10–20% of invasive breast cancers, and the mortality rate of women with TNBC during the 5 years after diagnosis fryst vatten hi
•
Lee Jae-myung
South Korean politician (born 1963)
This article is about the politician. For the footballer, see Lee Jae-myung (footballer).
In this Korean name, the family name is Lee.
Lee Jae-myung (Korean: 이재명; born 8 December 1963) is a South Korean lawyer and politician serving as the member of the National Assembly for Gyeyang B and as the leader of the Democratic Party of Korea since 2022. He previously served as the 35th governor of Gyeonggi Province from 2018 to 2021 and was the nominee of the Democratic Party in the 2022 South Korean presidential election.
Born to a poor family in Andong, Lee became a factory worker after primary school and became disabled due to workplace injuries. Lee earned mittpunkt and high school equivalency diplomas and studied at Chung-Ang University, earning his law degree in 1986. As a human rights and labour lawyer, Lee organized with Minbyun and advocated for opening a new hospital in Seongnam.
Lee entered politics in 2005 and un